|Articles|February 1, 2016
- Applied Clinical Trials-02-01-2016
- Volume 25
- Issue 2
Applied Clinical Trials, February/March 2016 Issue (PDF)
Click the title above to open the Applied Clinical Trials February/March 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 10 years ago
FDA Looks to New Techology, Policies to Streamline Clinical Researchover 10 years ago
EMA Adopts New Strategy on Measuring Impact of Pharmacovigilanceover 10 years ago
Ambition vs. Assessment: The Approval-Reimbursement Divideover 10 years ago
How Do You View the Future of Wearables?over 10 years ago
Competitive Pressure for First-in-Class Drugs is Intensifyingover 10 years ago
What Google Can Teach Us About Trial Education, Awarenessover 10 years ago
Preventing Patient Centricity from Becoming a Fadover 10 years ago
Clinical Trial Knowledge Missed, Gained, and Sharedover 10 years ago
Investigator Characteristics & Patient Recruitment in ALLHATover 10 years ago
Barriers to Trial Recruitment and Possible SolutionsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
2
ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access
3
ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion
4
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
5